Cancer drug data supports advanced trials - AstraZeneca
June 03, 2014 at 10:57 AM EDT
CHICAGO, June 3 (Reuters) - Britain's AstraZeneca Plc on Tuesday said data from early-stage trials of its experimental cancer drug, MEDI4736, are encouraging and support moving the immunotherapy into pivotal-stage testing.
